I talked about Idexx laboratories (Idexx) back in October 2019 when the counter was trading at USD272/share and was valued at close to 60x PER. My conclusion then was that despite its hefty valuation, the counter can still generate an after-inflation return of 7.6% on my base/mid-case scenario using Buffett-style analysis and deserve an entry. … Read more
Stocks that consistently outperform the market tend to have a few common characteristics. In Part 1 of our article, we highlighted 4 Outperforming stocks that have consistently beaten the market over the last decade. These 4 stocks are Apple, Adobe, Clorox, and Fastenal. 8 Outperforming Stocks to buy now (Part 1) We identified that all … Read more
